RESULTS	Although no differences in physical limitation scores were noted , patients randomized to receive long-acting medications had improved symptom control ( 3-month improvement in anginal stability [ 19.1 vs 5.6 , P = .02 ] and anginal frequency [ 17.8 vs 5.5 , P = .006 ] ) , more treatment satisfaction ( 3-month improvement of 8.2 vs 3.0 , P = .057 ) , and better quality of life ( 3-month improvement of 11.2 vs 5.6 , P = .09 ) compared with patients whose pretrial medications were optimized .\